Pier 88 Investment Partners LLC Seer, Inc. Transaction History

Pier 88 Investment Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$5.03 - $8.58 $5,507 - $9,395	-1,095 Reduced 14.23%	6,600 $38,000
Q3 2022 Nov 14, 2022	SELL	$7.7 - $13.31 $9,471 - $16,371	-1,230 Reduced 13.78%	7,695 $60,000
Q2 2022 Aug 12, 2022	SELL	$6.72 - $16.07 $25,536 - $61,066	-3,800 Reduced 29.86%	8,925 $80,000
Q1 2022 May 13, 2022	BUY	$11.88 - $23.4 $34,095 - $67,158	2,870 Added 29.12%	12,725 $194,000
Q4 2021 Feb 14, 2022	BUY	$21.08 - $38.51 $84,109 - $153,654	3,990 Added 68.03%	9,855 $225,000
Q3 2021 Nov 12, 2021	SELL	$27.67 - $45.04 $592,968 - $965,207	-21,430 Reduced 78.51%	5,865 $203,000
Q2 2021 Aug 13, 2021	BUY	$28.75 - $56.92 $546,250 - $1.08 Million	19,000 Added 229.05%	27,295 $895,000
Q1 2021 May 14, 2021	BUY	$38.67 - $84.06 $320,767 - $697,277	8,295 New	8,295 $415,000

39.7M

100

100

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $115M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Pier 88 Investment Partners LLC with notifications on news.